Tower Research Capital LLC (Trc) Oncocyte Corp Transaction History

Tower Research Capital LLC (Trc)

$3.68 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$0.2 - $0.35 $2,312 - $4,046	11,561 Added 30.24%	49,797 $11,000
Q1 2023 May 09, 2023	BUY	$0.2 - $0.49 $4,256 - $10,428	21,282 Added 125.53%	38,236 $14,000
Q4 2022 Feb 10, 2023	BUY	$0.25 - $15.6 $862 - $53,820	3,450 Added 25.55%	16,954 $5,000
Q3 2022 Nov 10, 2022	SELL	$0.76 - $15.98 $880 - $18,504	-1,158 Reduced 7.9%	13,504 $10,000
Q2 2022 Aug 15, 2022	SELL	$0.86 - $1.53 $686 - $1,220	-798 Reduced 5.16%	14,662 $13,000
Q1 2022 May 12, 2022	BUY	$1.15 - $2.25 $1,917 - $3,750	1,667 Added 12.09%	15,460 $23,000
Q4 2021 Feb 14, 2022	BUY	$2.04 - $3.59 $13,311 - $23,424	6,525 Added 89.78%	13,793 $30,000
Q3 2021 Nov 15, 2021	BUY	$3.53 - $5.89 $2,654 - $4,429	752 Added 11.54%	7,268 $26,000
Q2 2021 Aug 16, 2021	BUY	$3.77 - $6.0 $13,590 - $21,630	3,605 Added 123.84%	6,516 $37,000
Q1 2021 May 17, 2021	SELL	$2.39 - $6.5 $25,099 - $68,263	-10,502 Reduced 78.3%	2,911 $15,000
Q4 2020 Feb 16, 2021	SELL	$1.38 - $2.63 $55,332 - $105,452	-40,096 Reduced 74.93%	13,413 $32,000
Q3 2020 Nov 16, 2020	BUY	$1.2 - $1.89 $53,887 - $84,872	44,906 Added 521.98%	53,509 $74,000
Q2 2020 Aug 13, 2020	BUY	$1.91 - $3.45 $4,100 - $7,407	2,147 Added 33.26%	8,603 $17,000
Q1 2020 May 15, 2020	BUY	$1.76 - $3.02 $8,624 - $14,798	4,900 Added 314.91%	6,456 $16,000
Q4 2019 Feb 07, 2020	BUY	$1.51 - $2.27 $1,053 - $1,584	698 Added 81.35%	1,556 $4,000
Q3 2019 Nov 05, 2019	BUY	$1.59 - $2.51 $1,205 - $1,902	758 Added 758.0%	858 $2,000
Q2 2019 Aug 13, 2019	SELL	$2.49 - $5.45 $7,111 - $15,565	-2,856 Reduced 96.62%	100 $0
Q1 2019 May 14, 2019	BUY	$1.47 - $5.91 $682 - $2,742	464 Added 18.62%	2,956 $12,000
Q4 2018 Feb 14, 2019	BUY	$1.38 - $2.59 $3,438 - $6,454	2,492 New	2,492 $3,000
Q2 2018 Aug 15, 2018	SELL	$2.0 - $3.3 $2,468 - $4,072	-1,234 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$1.25 - $4.6 $698 - $2,571	559 Added 82.81%	1,234 $3,000
Q4 2017 Feb 09, 2018	BUY	$3.9 - $7.4 $2,632 - $4,995	675	675 $3,000

Others Institutions Holding OCX

# of Institutions

Shares Held

399K

Call Options Held

Put Options Held

View Full List

About Oncocyte Corp

Ticker OCX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 118,609,000
Market Cap $246M
Description
OncoCyte Corporation, a molecular diagnostics company, researches, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test for early-stage adenocarcinoma of the lung; and DetermaIO, a proprietary gene expression assay....

More about OCX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tower Research Capital LLC (Trc), based on Form 13F filings with the SEC.

News

Stay updated on Tower Research Capital LLC (Trc) with notifications on news.

Account